HK1087704A1 - Quinuclidine derivatives binding to mucarinic m3 receptors - Google Patents

Quinuclidine derivatives binding to mucarinic m3 receptors

Info

Publication number
HK1087704A1
HK1087704A1 HK06107974.9A HK06107974A HK1087704A1 HK 1087704 A1 HK1087704 A1 HK 1087704A1 HK 06107974 A HK06107974 A HK 06107974A HK 1087704 A1 HK1087704 A1 HK 1087704A1
Authority
HK
Hong Kong
Prior art keywords
mucarinic
receptors
quinuclidine derivatives
derivatives binding
binding
Prior art date
Application number
HK06107974.9A
Other languages
English (en)
Inventor
Stephen Paul Collingwood
Brian Cox
Urs Baettig
Gurdip Bhalay
Nicholas James Devereux
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33420896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1087704(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0324887A external-priority patent/GB0324887D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1087704A1 publication Critical patent/HK1087704A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK06107974.9A 2003-05-02 2006-07-17 Quinuclidine derivatives binding to mucarinic m3 receptors HK1087704A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0310232 2003-05-02
GB0324887A GB0324887D0 (en) 2003-10-24 2003-10-24 Organic compounds
PCT/EP2004/004605 WO2004096800A2 (fr) 2003-05-02 2004-04-30 Composes organiques

Publications (1)

Publication Number Publication Date
HK1087704A1 true HK1087704A1 (en) 2006-10-20

Family

ID=33420896

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06107974.9A HK1087704A1 (en) 2003-05-02 2006-07-17 Quinuclidine derivatives binding to mucarinic m3 receptors

Country Status (32)

Country Link
US (2) US20070060563A1 (fr)
EP (1) EP1631569B1 (fr)
JP (1) JP4416786B2 (fr)
KR (1) KR100896544B1 (fr)
AR (1) AR044134A1 (fr)
AT (1) ATE440840T1 (fr)
AU (1) AU2004234069B2 (fr)
BR (1) BRPI0410238A (fr)
CA (1) CA2523436C (fr)
CL (1) CL2004000918A1 (fr)
CO (1) CO5700782A2 (fr)
CY (1) CY1109655T1 (fr)
DE (1) DE602004022805D1 (fr)
DK (1) DK1631569T3 (fr)
EC (1) ECSP056134A (fr)
ES (1) ES2331185T3 (fr)
HK (1) HK1087704A1 (fr)
HR (1) HRP20050933A2 (fr)
IL (1) IL171591A (fr)
IS (1) IS2746B (fr)
MA (1) MA27775A1 (fr)
MX (1) MXPA05011739A (fr)
MY (1) MY142652A (fr)
NO (1) NO20055688L (fr)
NZ (1) NZ542995A (fr)
PE (1) PE20050465A1 (fr)
PL (1) PL1631569T3 (fr)
PT (1) PT1631569E (fr)
RU (1) RU2363700C2 (fr)
SI (1) SI1631569T1 (fr)
TW (1) TWI340139B (fr)
WO (1) WO2004096800A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239546B1 (es) * 2004-03-15 2006-12-01 Almirall Prodesfarma, S.A. Nuevos esteres de quinuclidina cuaternizados.
GB0410712D0 (en) 2004-05-13 2004-06-16 Novartis Ag Organic compounds
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0428416D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
EP1900737A1 (fr) * 2006-08-31 2008-03-19 Novartis AG Polymorphe de (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
EP1894568A1 (fr) * 2006-08-31 2008-03-05 Novartis AG Composées pharmaceutiques destinées au traitement des maladies inflammatoires ou obstructives des bronches
TW200825084A (en) * 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
CA2672446A1 (fr) * 2006-12-19 2008-06-26 Astrazeneca Ab Derives quinuclidinol utilises en tant qu'antagonistes du recepteur muscarinique
EP1950196A1 (fr) * 2007-01-29 2008-07-30 Boehringer Ingelheim Pharma GmbH & Co. KG Procédé de fabrication d'hexafluorophosphates d'ammonium
RU2480458C2 (ru) * 2007-09-07 2013-04-27 Тереванс, Инк. Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов
JP2011506477A (ja) 2007-12-14 2011-03-03 セラヴァンス， インコーポレーテッド ムスカリン受容体拮抗薬として有用なアミジン含有化合物
PT2231642E (pt) 2008-01-11 2014-03-12 Novartis Ag Pirimidinas como inibidores de quinase
GB0808709D0 (en) * 2008-05-13 2008-06-18 Astrazeneca Ab New combination 295
MX2010012019A (es) * 2008-05-13 2011-03-04 Astrazeneca Ab Producto farmaceutico que comprende un antagonista receptor muscarinico y un agonista de adrenoceptor beta2.
JP4837800B2 (ja) * 2008-05-13 2011-12-14 アストラゼネカ・アクチエボラーグ ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体
US20090326004A1 (en) 2008-06-03 2009-12-31 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
WO2009153536A1 (fr) * 2008-06-17 2009-12-23 Argenta Discovery Limited Dérivés de 1-aza-bicyclo [2.2.2] octane utiles en tant qu’antagonistes des récepteurs muscariniques
GB0811100D0 (en) * 2008-06-17 2008-07-23 Astrazeneca Ab New combination
WO2011161018A1 (fr) * 2010-06-22 2011-12-29 Chiesi Farmaceutici S.P.A. Dérivés aminoester d'alcaloïdes et compositions médicinales les comprenant
WO2012034095A1 (fr) 2010-09-09 2012-03-15 Irm Llc Composés et compositions comme inhibiteurs de trk
UY33597A (es) 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
CA2828219A1 (fr) 2011-02-25 2012-08-30 Irm Llc Composes et compositions en tant qu'inhibiteurs de trk
JP2011195593A (ja) * 2011-06-30 2011-10-06 Astrazeneca Ab ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体
EP2797910B1 (fr) * 2011-12-30 2015-09-16 Chiesi Farmaceutici S.p.A. Esters de quinuclidine et d'acide 1-azahétérocyclylacétique utilisés comme agents antimuscariniques, procédé pour leur préparation et compositions médicinales correspondantes
US9687488B2 (en) 2012-05-03 2017-06-27 St. Louis College Of Pharmacy Compositions and methods for increasing neurotrophic peptides
TWI647227B (zh) * 2013-02-28 2019-01-11 日商安斯泰來製藥股份有限公司 ２－醯胺噻唑衍生物或其鹽
CZ306791B6 (cs) 2013-10-29 2017-07-12 Zentiva, K.S. Průmyslově využitelný způsob přípravy aklidinium bromidu o vysoké čistotě
PT108370B (pt) * 2015-03-30 2018-10-25 Hovione Farm S A Processo de preparação de brometo de aclidínio
EP3111978B1 (fr) 2015-07-03 2021-09-01 Novartis AG Inhalateur conçu pour lire des informations stockées dans un dispositif de stockage de données d'un récipient

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1219606A (en) * 1968-07-15 1971-01-20 Rech S Et D Applic Scient Soge Quinuclidinol derivatives and preparation thereof
DK534178A (da) * 1977-12-16 1979-06-17 Interx Research Corp Anticholinerge midler med sektrtionshaemmende virkning
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US6846835B2 (en) * 2000-07-11 2005-01-25 Banyu Pharmaceutical Co., Ltd. Ester derivatives
AU2002238471B2 (en) * 2000-12-28 2007-06-28 Almirall, S.A. Quinuclidine derivatives and their use as M3 antagonists
KR100944580B1 (ko) * 2001-12-20 2010-02-25 치에시 파마슈티시 에스.피.아. 1-알킬-1-아조니아비시클로[2.2.2]옥탄 카르바메이트유도체 및 이의 무스카린 수용체 길항제로서의 용도
GB0424284D0 (en) * 2004-11-02 2004-12-01 Novartis Ag Organic compounds
EP1900737A1 (fr) * 2006-08-31 2008-03-19 Novartis AG Polymorphe de (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide

Also Published As

Publication number Publication date
IS2746B (is) 2011-08-15
SI1631569T1 (sl) 2010-01-29
US20100041887A1 (en) 2010-02-18
PL1631569T3 (pl) 2010-02-26
KR100896544B1 (ko) 2009-05-07
ATE440840T1 (de) 2009-09-15
DK1631569T3 (da) 2009-11-23
WO2004096800A2 (fr) 2004-11-11
AU2004234069A1 (en) 2004-11-11
AR044134A1 (es) 2005-08-24
PE20050465A1 (es) 2005-07-18
CA2523436A1 (fr) 2004-11-11
EP1631569B1 (fr) 2009-08-26
MXPA05011739A (es) 2006-01-26
EP1631569A2 (fr) 2006-03-08
NZ542995A (en) 2009-02-28
RU2363700C2 (ru) 2009-08-10
US8168654B2 (en) 2012-05-01
DE602004022805D1 (de) 2009-10-08
CL2004000918A1 (es) 2005-02-11
KR20060015572A (ko) 2006-02-17
HRP20050933A2 (en) 2006-12-31
PT1631569E (pt) 2009-11-26
ES2331185T3 (es) 2009-12-23
CA2523436C (fr) 2011-11-01
JP2006525267A (ja) 2006-11-09
RU2005137360A (ru) 2006-07-27
CY1109655T1 (el) 2014-08-13
TW200505920A (en) 2005-02-16
JP4416786B2 (ja) 2010-02-17
WO2004096800A3 (fr) 2005-01-06
IS8158A (is) 2005-11-30
NO20055688D0 (no) 2005-12-01
MY142652A (en) 2010-12-15
ECSP056134A (es) 2006-04-19
CO5700782A2 (es) 2006-11-30
IL171591A (en) 2010-11-30
TWI340139B (en) 2011-04-11
NO20055688L (no) 2006-01-09
AU2004234069B2 (en) 2008-02-21
BRPI0410238A (pt) 2006-05-16
US20070060563A1 (en) 2007-03-15
MA27775A1 (fr) 2006-02-01

Similar Documents

Publication Publication Date Title
HK1087704A1 (en) Quinuclidine derivatives binding to mucarinic m3 receptors
HK1199266A1 (en) Specific binding agents to hepatocyte growth factor
TWI365883B (en) Antibodies to m-csf
TWI366570B (en) Antibodies to madcam
IL172276A0 (en) Cross-reference to related application
EP1708703A4 (fr) Composes de liaison aux recepteurs de la chemokine
GB0411123D0 (en) High-affinity NY-ESO T cell receptors
GB0404953D0 (en) Pro-drugs
GB0312539D0 (en) Improvements relating to gutters
TW588733U (en) Improved structure for binding band
ZA200703442B (en) Proline derivatives
GB0328694D0 (en) Improvement to tees
GB0421028D0 (en) Improvements relating to books
GB0413163D0 (en) Improvements to signware
GB0418566D0 (en) Tropane derivatives
GB0717454D0 (en) Improvements to road saftey
GB0412701D0 (en) Improvements relating to jigs
GB0417688D0 (en) Pro-drugs
GB0404955D0 (en) Pro-drugs
GB0404637D0 (en) Waterproof airbrick
GB0407374D0 (en) Improvements to equipment
PL362000A1 (en) Binder

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130430